Global Implantable Infusion Pumps Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2026

According to Data Bridge Market Research new Market report, global implantable infusion pumps market will account to an estimated USD 12579.90 million in 2018 growing at a CAGR of 5.87% during the forecast period of 2019 to 2026.

Access Full Report at

Global Implantable Infusion Pumps Market

Implantable infusions pumps are devices that are implanted under the skin, usually in abdominal region to deliver long-term drug infusion to the patients through intra-arterial, intra venous, subcutaneous, intraperitoneal, intrathecal route and epidural. In simple words, they are used to deliver medications and fluids within the body. They are usually used to treat chronic pain, muscle spasticity etc. High level of sophistication is required to run these pumps.

Segmentation: Global Implantable Infusion Pumps Market

Global implantable infusion pumps market is segmented on the basis products, applications, end- user and geography.

By Product (Piston Type Infusion Pumps, Creeping Type Infusion Pumps), Application (Cancer Treatment, Spasticity, Analgesia, Diabetes Mellitus, Others), End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), Geography (Europe, North America, Asia Pacific, South America and Middle East & Africa)


Rising of Incidence Rate of Cancer

According to WHO, in 2018 18.4 % of people died from lung cancer, 9.2% from colorectal cancer, 8.2% from stomach and liver cancer respectively, 6.6% from breast cancer, 5.3% from oesophagus cancer, 4.5% from pancreas cancer, 3.8% from prostate and 35.8% from other cancers. Approximately, 9555027 deaths happened in 2018.

In U.S. approximately 891thousand new cancer cases will be there in 2019 among women and approximately 870 thousand cases among man in 2019. It is estimated that around 1762450 new cancer cases will be there in 2019.

Key Market Competitors: Global Implantable Infusion Pumps Market

Few of the major market competitors currently working in the implantable infusion pumps market are BD, Baxter, ICU Medical, Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Medtronic, Smiths Medical, TERUMO CORPORATION, Moog Inc., F. Hoffmann-La Roche Ltd, O&M Halyard or its affiliates., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Micrel Medical, Insulet Corporation.

Browse Related Reports:

Global Implantable Drug Delivery Market By Product Type (Implantable Bio-Absorbable Stents, Implantable Contraceptive Drug Delivery Devices, Implantable Intraocular Drug Delivery Devices, Implantable Coronary Drug Eluting Stents, Implantable Brachytherapy Seeds And Implantable Drug Infusion Pumps), Technology, Application, Geography (North America, South America, Europe, Asia-Pacific, Middle East And Africa)- Industry Trends and Forecast to 2025

Global Active Implantable Medical Devices Market Product (Implantable Cardioverter Defibrillators {Transvenous, Subcutaneous}, Ventricular Assist Devices, Implantable Cardiac Pacemakers, Dental Implants, Implantable Hearing Devices, Ventricular Assist Devices, Neurostimulators), End-Users (Hospitals, Ambulatory Centers, Cardiac centers, Dental Clinics, Others), Geography- Industry Trends and Forecast to 2024

Global ENT Devices Market By Product (Diagnostic devices, Surgical devices, Hearing Aids, Hearing implants,Co2 Lasers, Image-Guided Surgery Systems), End User (Hospitals, ASC’s, ENT clinics and Homecare), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026